Alembic Pharma gets USFDA Final nod for Lurasidone Hydrochloride Tablets EP News Bureau May 14, 2021 They are indicated for monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode…
Alembic Pharma gets USFDA final approval for Asenapine Sublingual Tablets EP News Bureau Dec 11, 2020 Asenapine is an atypical antipsychotic indicated for bipolar I disorder as adjunctive treatment to lithium or valproate in adults
